Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages

Authors: Hemavathy Harikrishnan, Ibrahim Jantan, Md. Areeful Haque, Endang Kumolosasi

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Phyllanthus amarus has been used widely in various traditional medicines to treat swelling, sores, jaundice, inflammatory diseases, kidney disorders, diabetes and viral hepatitis, while its pharmacological and biochemical mechanisms underlying its anti-inflammatory properties have not been well investigated. The present study was carried out to investigate the effects of 80% ethanolic extract of P. amarus on pro-inflammatory mediators release in nuclear factor-kappa B (NF-кB), mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase/Akt (PI3K-Akt) signaling activation in lipopolysaccharide (LPS)-induced U937 human macrophages.

Methods

The release of prostaglandin E2 (PGE2) and pro-inflammatory cytokines, tumor necrosis factor (TNF)-α and interleukin (IL)-1β in a culture supernatant was determined by ELISA. Determination of cyclooxygenase-2 (COX-2) protein and the activation of MAPKs molecules (JNK, ERK and p38 MAPK), NF-κB and Akt in LPS-induced U937 human macrophages were investigated by immunoblot technique. The relative gene expression levels of COX-2 and pro-inflammatory cytokines were measured by using qRT-PCR. The major metabolites of P. amarus were qualitatively and quantitatively analyzed in the extract by using validated reversed-phase high performance liquid chromatography (HPLC) methods.

Results

P. amarus extract significantly inhibited the production of pro-inflammatory mediators (TNF-α, IL-1β, PGE2) and COX-2 protein expression in LPS-induced U937 human macrophages. P. amarus-pretreatment also significantly downregulated the increased mRNA transcription of pro-inflammatory markers (TNF-α, IL-1β, and COX-2) in respective LPS-induced U937 macrophages. It downregulated the phosphorylation of NF-κB (p65), IκBα, and IKKα/β and restored the degradation of IκBα, and attenuated the expression of Akt, JNK, ERK, and p38 MAPKs phosphorylation in a dose-dependent manner. P. amarus extract also downregulated the expression of upstream signaling molecules, TLR4 and MyD88, which play major role in activation of NF-κB, MAPK and PI3K-Akt signaling pathways. The quantitative amounts of lignans, phyllanthin, hypophyllahtin and niranthin, and polyphenols, gallic acid, geraniin, corilagin, and ellagic acid in the extract were determined by HPLC analysis.

Conclusion

The study revealed that P. amarus targeted the NF-κB, MAPK and PI3K-Akt signaling pathways to exert its anti- inflammatory effects by downregulating the prospective inflammatory signaling mediators.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haque MA, Jantan I, Harikrishnan H. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways. Int Immunopharmacol. 2018;55:312–22.CrossRefPubMed Haque MA, Jantan I, Harikrishnan H. Zerumbone suppresses the activation of inflammatory mediators in LPS-stimulated U937 macrophages through MyD88-dependent NF-κB/MAPK/PI3K-Akt signaling pathways. Int Immunopharmacol. 2018;55:312–22.CrossRefPubMed
4.
go back to reference Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16(2):217–226, 229. discussion 230-212PubMed Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16(2):217–226, 229. discussion 230-212PubMed
5.
go back to reference Killeen MJ, Linder M, Pontoniere P, Crea R. NF-kappabeta signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities. Drug Discov Today. 2014;19(4):373–8.CrossRefPubMed Killeen MJ, Linder M, Pontoniere P, Crea R. NF-kappabeta signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities. Drug Discov Today. 2014;19(4):373–8.CrossRefPubMed
7.
go back to reference Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–63.CrossRefPubMed Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–63.CrossRefPubMed
8.
go back to reference Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778–88.CrossRefPubMed Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778–88.CrossRefPubMed
9.
go back to reference Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13(2):85–94.CrossRefPubMed Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13(2):85–94.CrossRefPubMed
10.
go back to reference Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol. 2010;42(4):519–23.CrossRefPubMed Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol. 2010;42(4):519–23.CrossRefPubMed
11.
go back to reference Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatol. 2008;47(4):409–14.CrossRef Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatol. 2008;47(4):409–14.CrossRef
12.
go back to reference Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 1998;273(6):3285–90.CrossRefPubMed Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 1998;273(6):3285–90.CrossRefPubMed
13.
go back to reference Hwang PA, Chien SY, Chan YL, Lu MK, Wu CH, Kong ZL, Wu CJ. Inhibition of lipopolysaccharide (LPS)-induced inflammatory responses by Sargassum hemiphyllum sulfated polysaccharide extract in RAW 264.7 macrophage cells. J Agric Food Chem. 2011;59(5):2062–8.CrossRefPubMed Hwang PA, Chien SY, Chan YL, Lu MK, Wu CH, Kong ZL, Wu CJ. Inhibition of lipopolysaccharide (LPS)-induced inflammatory responses by Sargassum hemiphyllum sulfated polysaccharide extract in RAW 264.7 macrophage cells. J Agric Food Chem. 2011;59(5):2062–8.CrossRefPubMed
14.
go back to reference Paccani SR, Boncristiano M, Ulivieri C, D’Elios MM, Del Prete G, Baldari CT. Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J Biol Chem. 2002;277(2):1509–13.CrossRefPubMed Paccani SR, Boncristiano M, Ulivieri C, D’Elios MM, Del Prete G, Baldari CT. Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J Biol Chem. 2002;277(2):1509–13.CrossRefPubMed
15.
go back to reference Patil VV, Bhangale SC, Patil VR. Studies on immunomodulatory activity of Ficus carica. Int J Pharm Pharm Sci. 2010;2(4):97–9. Patil VV, Bhangale SC, Patil VR. Studies on immunomodulatory activity of Ficus carica. Int J Pharm Pharm Sci. 2010;2(4):97–9.
16.
go back to reference Jayathirtha MG, Mishra SH. Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine. 2004;11(4):361–5.CrossRefPubMed Jayathirtha MG, Mishra SH. Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine. 2004;11(4):361–5.CrossRefPubMed
17.
go back to reference Patel JR, Tripathi P, Sharma V, Chauhan NS, Dixit VK. Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol. 2011;138(2):286–313.CrossRefPubMed Patel JR, Tripathi P, Sharma V, Chauhan NS, Dixit VK. Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol. 2011;138(2):286–313.CrossRefPubMed
18.
go back to reference Calixto JB, Santos AR, Cechinel Filho V, Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev. 1998;18(4):225–58.CrossRefPubMed Calixto JB, Santos AR, Cechinel Filho V, Yunes RA. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev. 1998;18(4):225–58.CrossRefPubMed
19.
go back to reference Harikrishnan H, Jantan I, Haque MA, Kumolosasi E. Anti-inflammatory effects of hypophyllanthin and niranthin through downregulation of NF-κB/MAPKs/PI3K-Akt signaling pathways. Inflammation. 2018;41(3):984–95.CrossRefPubMed Harikrishnan H, Jantan I, Haque MA, Kumolosasi E. Anti-inflammatory effects of hypophyllanthin and niranthin through downregulation of NF-κB/MAPKs/PI3K-Akt signaling pathways. Inflammation. 2018;41(3):984–95.CrossRefPubMed
20.
go back to reference Foo LY. Amariin, a di-dehydrohexahydroxydiphenoyl hydrolysable tannin from Phyllanthus amarus. Phytochemistry. 1993;33(2):487–91.CrossRef Foo LY. Amariin, a di-dehydrohexahydroxydiphenoyl hydrolysable tannin from Phyllanthus amarus. Phytochemistry. 1993;33(2):487–91.CrossRef
21.
go back to reference Sharma A, Singh RT, Handa SS. Estimation of phyllanthin and hypophyllanthin by high performance liquid chromatography in Phyllanthus amarus. Phytochem Anal. 1993;4(5):226–9.CrossRef Sharma A, Singh RT, Handa SS. Estimation of phyllanthin and hypophyllanthin by high performance liquid chromatography in Phyllanthus amarus. Phytochem Anal. 1993;4(5):226–9.CrossRef
22.
go back to reference Houghton PJ, Woldemariam TZ, O'Shea S, Thyagarajan S. Two securinega-type alkaloids from Phyllanthus amarus. Phytochemistry. 1996;43(3):715–7.CrossRef Houghton PJ, Woldemariam TZ, O'Shea S, Thyagarajan S. Two securinega-type alkaloids from Phyllanthus amarus. Phytochemistry. 1996;43(3):715–7.CrossRef
23.
go back to reference Moronkola DO, Ogunwande IA, Oyewole IO, Başer KHC, Ozek T, Ozek G. Studies on the volatile oils of Momordica charantia L. (Cucurbitaceae) and Phyllanthus amarus Sch. Et Thonn (Euphorbiaceae). J Essent Oil Res. 2009;21(5):393–9.CrossRef Moronkola DO, Ogunwande IA, Oyewole IO, Başer KHC, Ozek T, Ozek G. Studies on the volatile oils of Momordica charantia L. (Cucurbitaceae) and Phyllanthus amarus Sch. Et Thonn (Euphorbiaceae). J Essent Oil Res. 2009;21(5):393–9.CrossRef
24.
go back to reference Mahat M, Patil B. Evaluation of antiinflammatory activity of methanol extract of Phyllanthus amarus in experimental animal models. Indian J Pharm Sci. 2007;69(1):33.CrossRef Mahat M, Patil B. Evaluation of antiinflammatory activity of methanol extract of Phyllanthus amarus in experimental animal models. Indian J Pharm Sci. 2007;69(1):33.CrossRef
25.
go back to reference Kassuya CA, Silvestre A, Menezes-de-Lima O, Marotta DM, Rehder VLG, Calixto JB. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: evidence for interaction with platelet activating factor receptor. Eur J Pharmacol. 2006;546(1):182–8.CrossRefPubMed Kassuya CA, Silvestre A, Menezes-de-Lima O, Marotta DM, Rehder VLG, Calixto JB. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: evidence for interaction with platelet activating factor receptor. Eur J Pharmacol. 2006;546(1):182–8.CrossRefPubMed
26.
go back to reference Yuandani IM, Jantan I, Mohamad HF, Husain K, Abdul Razak AF. Inhibitory effects of standardized extracts of Phyllanthus amarus and Phyllanthus urinaria and their marker compounds on phagocytic activity of human neutrophils. Evid Based Complement Alternat Med. 2013;2013:603634.CrossRefPubMedPubMedCentral Yuandani IM, Jantan I, Mohamad HF, Husain K, Abdul Razak AF. Inhibitory effects of standardized extracts of Phyllanthus amarus and Phyllanthus urinaria and their marker compounds on phagocytic activity of human neutrophils. Evid Based Complement Alternat Med. 2013;2013:603634.CrossRefPubMedPubMedCentral
27.
go back to reference Jantan I, Ilangkovan M, Mohamad HF. Correlation between the major components of Phyllanthus amarus and Phyllanthus urinaria and their inhibitory effects on phagocytic activity of human neutrophils. BMC Complement Altern Med. 2014;14(1):429.CrossRefPubMedCentral Jantan I, Ilangkovan M, Mohamad HF. Correlation between the major components of Phyllanthus amarus and Phyllanthus urinaria and their inhibitory effects on phagocytic activity of human neutrophils. BMC Complement Altern Med. 2014;14(1):429.CrossRefPubMedCentral
28.
go back to reference Ilangkovan M, Jantan I, Mesaik MA, Bukhari SNA. Immunosuppressive effects of the standardized extract of Phyllanthus amarus on cellular immune responses in Wistar-Kyoto rats. Drug Des Dev Ther. 2015;9:4917. Ilangkovan M, Jantan I, Mesaik MA, Bukhari SNA. Immunosuppressive effects of the standardized extract of Phyllanthus amarus on cellular immune responses in Wistar-Kyoto rats. Drug Des Dev Ther. 2015;9:4917.
29.
go back to reference Ilangkovan M, Jantan I, Mesaik MA, Bukhari SNA. Inhibitory effects of the standardized extract of Phyllanthus amarus on cellular and humoral immune responses in Balb/C mice. Phytother Res. 2016;30(8):1330–8.CrossRefPubMed Ilangkovan M, Jantan I, Mesaik MA, Bukhari SNA. Inhibitory effects of the standardized extract of Phyllanthus amarus on cellular and humoral immune responses in Balb/C mice. Phytother Res. 2016;30(8):1330–8.CrossRefPubMed
30.
go back to reference Sock-Jin L, Kumolosasi E, Azmi N, Bukhari SNA, Jasamai M, Fauzi NM. Effects of synthetic chalcone derivatives on oxidised palmitoyl arachidonoyl phosphorylcholine-induced proinflammatory chemokines production. RSC Adv. 2015;5(84):68773–80.CrossRef Sock-Jin L, Kumolosasi E, Azmi N, Bukhari SNA, Jasamai M, Fauzi NM. Effects of synthetic chalcone derivatives on oxidised palmitoyl arachidonoyl phosphorylcholine-induced proinflammatory chemokines production. RSC Adv. 2015;5(84):68773–80.CrossRef
31.
go back to reference Aluwi MFFM, Rullah K, Haque MA, Yamin BM, Ahmad W, Amjad MW, Leong SW, Fahmizar NA, Jalil J, Abas F. Suppression of PGE2 production via disruption of MAPK phosphorylation by unsymmetrical dicarbonyl curcumin derivatives. Med Chem Res. 2017;26(12):3323–35.CrossRef Aluwi MFFM, Rullah K, Haque MA, Yamin BM, Ahmad W, Amjad MW, Leong SW, Fahmizar NA, Jalil J, Abas F. Suppression of PGE2 production via disruption of MAPK phosphorylation by unsymmetrical dicarbonyl curcumin derivatives. Med Chem Res. 2017;26(12):3323–35.CrossRef
32.
go back to reference Kiemer AK, Hartung T, Huber C, Vollmar AM. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway. J Hepatol. 2003;38(3):289–97.CrossRefPubMed Kiemer AK, Hartung T, Huber C, Vollmar AM. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway. J Hepatol. 2003;38(3):289–97.CrossRefPubMed
33.
go back to reference Ilangkovan M, Jantan I, Mohamad HF, Husain K, Abdul Razak AF. Inhibitory effects of standardized extracts of Phyllanthus amarus and Phyllanthus urinaria and their marker compounds on phagocytic activity of human neutrophils. Evid Based Complement Alternat Med. 2013;2013, Art. ID. 603634. p. 9. Ilangkovan M, Jantan I, Mohamad HF, Husain K, Abdul Razak AF. Inhibitory effects of standardized extracts of Phyllanthus amarus and Phyllanthus urinaria and their marker compounds on phagocytic activity of human neutrophils. Evid Based Complement Alternat Med. 2013;2013, Art. ID. 603634. p. 9.
34.
go back to reference Yuandani IJ, Ilangkovan M, Husain K, Chan KM. Inhibitory effects of compounds from Phyllanthus amarus on nitric oxide production, lymphocyte proliferation, and cytokine release from phagocytes. Drug Des Dev Ther. 2016;10:1935. Yuandani IJ, Ilangkovan M, Husain K, Chan KM. Inhibitory effects of compounds from Phyllanthus amarus on nitric oxide production, lymphocyte proliferation, and cytokine release from phagocytes. Drug Des Dev Ther. 2016;10:1935.
35.
go back to reference Roh K-B, Kim H, Shin S, Kim Y-S, Lee J-A, Kim MO, Jung E, Lee J, Park D. Anti-inflammatory effects of Zea mays L. husk extracts. BMC Complement Altern Med. 2016;16(1):298.CrossRefPubMedPubMedCentral Roh K-B, Kim H, Shin S, Kim Y-S, Lee J-A, Kim MO, Jung E, Lee J, Park D. Anti-inflammatory effects of Zea mays L. husk extracts. BMC Complement Altern Med. 2016;16(1):298.CrossRefPubMedPubMedCentral
36.
go back to reference Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267(36):25934–8.PubMed Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267(36):25934–8.PubMed
37.
go back to reference Xie W, Chipman JG, Robertson DL, Erikson R, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci. 1991;88(7):2692–6.CrossRefPubMed Xie W, Chipman JG, Robertson DL, Erikson R, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci. 1991;88(7):2692–6.CrossRefPubMed
38.
go back to reference Mohamed SIA, Jantan I, Haque MA. Naturally occurring immunomodulators with antitumor activity: an insight on their mechanisms of action. Int Immunopharmacol. 2017;50:291–304.CrossRefPubMed Mohamed SIA, Jantan I, Haque MA. Naturally occurring immunomodulators with antitumor activity: an insight on their mechanisms of action. Int Immunopharmacol. 2017;50:291–304.CrossRefPubMed
39.
go back to reference Baraf HS. Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. Curr Pharm Des. 2007;13(22):2228–36.CrossRefPubMed Baraf HS. Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. Curr Pharm Des. 2007;13(22):2228–36.CrossRefPubMed
40.
go back to reference Tham CL, Liew CY, Lam KW, Mohamad A-S, Kim MK, Cheah YK, Zakaria Z-A, Sulaiman M-R, Lajis NH, Israf DA. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur J Pharmacol. 2010;628(1–3):247–54.CrossRefPubMed Tham CL, Liew CY, Lam KW, Mohamad A-S, Kim MK, Cheah YK, Zakaria Z-A, Sulaiman M-R, Lajis NH, Israf DA. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur J Pharmacol. 2010;628(1–3):247–54.CrossRefPubMed
41.
go back to reference Bertholet S, Tzeng E, Felley-Bosco E, Mauel J. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol. 1999;65(1):50–8.CrossRefPubMed Bertholet S, Tzeng E, Felley-Bosco E, Mauel J. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol. 1999;65(1):50–8.CrossRefPubMed
42.
go back to reference Jung H-W, Seo U-K, Kim J-H, Leem K-H, Park Y-K. Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-κB signaling pathway in murine macrophages. J Ethnopharmacol. 2009;122(2):313–9.CrossRefPubMed Jung H-W, Seo U-K, Kim J-H, Leem K-H, Park Y-K. Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-κB signaling pathway in murine macrophages. J Ethnopharmacol. 2009;122(2):313–9.CrossRefPubMed
44.
go back to reference Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754(1–2):253–62.CrossRefPubMed Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754(1–2):253–62.CrossRefPubMed
45.
go back to reference Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol. 2009;85(6):966–77.CrossRefPubMedPubMedCentral Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol. 2009;85(6):966–77.CrossRefPubMedPubMedCentral
47.
go back to reference Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7(3):179.CrossRefPubMed Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7(3):179.CrossRefPubMed
48.
go back to reference Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2005;3(1):36.CrossRefPubMed Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2005;3(1):36.CrossRefPubMed
49.
go back to reference Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J. Contribution of toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatol. 2005;41(3):443–50.CrossRef Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J. Contribution of toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatol. 2005;41(3):443–50.CrossRef
Metadata
Title
Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages
Authors
Hemavathy Harikrishnan
Ibrahim Jantan
Md. Areeful Haque
Endang Kumolosasi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2289-3

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue